TrovaGene, Inc. Warrant
TROVW
TROVW was delisted on the 30th of May, 2017.
2 hedge funds and large institutions have $2.84M invested in TrovaGene, Inc. Warrant in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
30% more capital invested
Capital invested by funds: $2.18M → $2.84M (+$660K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
50% less funds holding
Funds holding: 4 → 2 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$257K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$62K |
| 2 |
Neuberger Berman Group
New York
|
-$62K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$641 |
TROVW Hedge Fund Activity: Q3 2013 in Review
2 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q3 2013, worth a combined $2.84M — up 30% from $2.18M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TROVW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Millennium Management, adding an estimated $257K. The largest seller was Morgan Stanley, exiting entirely with an estimated $62K sold.
- 2 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q3 2013, down from 4 in Q2 2013.
- Funds reported $2.84M of TrovaGene, Inc. Warrant stock for Q3 2013, up 30% quarter-over-quarter.
- 0 funds opened new TrovaGene, Inc. Warrant positions in Q3 2013 and 2 closed out, a net change of -2 holders.
- The largest TrovaGene, Inc. Warrant buyer in Q3 2013 was Millennium Management, an estimated $257K added.
- The largest TrovaGene, Inc. Warrant seller in Q3 2013 was Morgan Stanley, an estimated $62K sold.
Based on aggregated 13F filings for Q3 2013.